Pei Zhou
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Evaluation of pegylated interferon-α therapy efficacy in patients with inactive hepatitis B surface antigen carrier state.
Journal: Scandinavian journal of gastroenterology
Published: April 01, 2026
The CCL2-CCR2-Ly6c + macrophage axis in PegIFNα-2b therapy for chronic hepatitis B.
Journal: Immunobiology
Published: February 05, 2026
Astragaloside IV reduces hepatitis B surface antigen level via monocyte/macrophages in chronic HBV infection mice.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 30, 2025
Impact of Non-Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha.
Journal: Journal of viral hepatitis
Published: May 15, 2025
IQGAP3 deficiency leads to non-syndromic hearing loss via inhibition of CDC42 enzyme activity.
Journal: International journal of pediatric otorhinolaryngology
Published: January 17, 2025
Wybutosine hypomodification of tRNAphe activates HERVK and impairs neuronal differentiation.
Journal: iScience
Published: September 19, 2023
TMErisk score: A tumor microenvironment-based model for predicting prognosis and immunotherapy in patients with head and neck squamous cell carcinoma.
Journal: Heliyon
Published: May 08, 2023
An efficient cell culture system for the studies of heterogeneous astrocytes: Time gradient digestion.
Journal: Journal of neuroscience methods
Published: April 21, 2021
Zebrafish modeling mimics developmental phenotype of patients with RAPGEF1 mutation.
Journal: Clinical genetics
Published: December 24, 2020
Last Updated: 09/26/2026